Dexilant (Takeda Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the Dexilant drug offered from Takeda Pharmaceuticals America, Inc.. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Takeda Pharmaceuticals America, Inc. |
| NON-PROPRIETARY NAME: | dexlansoprazole |
| SUBSTANCE NAME: | DEXLANSOPRAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-04-12 |
| END MARKETING DATE: | 0000-00-00 |
Dexilant HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dexilant from Takeda Pharmaceuticals America, Inc. |
| LABELER NAME: | Takeda Pharmaceuticals America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30(mg/1) |
| START MARKETING DATE: | 2010-04-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64764-171_5a2130f7-fd80-40ef-8190-51e68f147bb0 |
| PRODUCT NDC: | 64764-171 |
| APPLICATION NUMBER: | NDA022287 |
Other DEXLANSOPRAZOLE Pharmaceutical Manufacturers / Labelers:
